Literature DB >> 1103999

Cell cycle dependency of a T-cell marker on lymphoblasts.

H U Schwenk, U Schneider.   

Abstract

A T-cell marker was expressed by the leukemic lymphoblasts of a 14 years old boy. After 14 days of cultivation, a permanently growing lymphoblastic cell line JM, which manifested the T-cell marker over the whole period of subcultivation, was established from the blood. In vitro synchronization experiments showed that this important cell marker in the G1 phase of the cell cycle is expressed on the surface of the blasts to a reduced degree, compared to the level in the other cell cycle phases.

Entities:  

Mesh:

Year:  1975        PMID: 1103999     DOI: 10.1007/bf01634146

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  Deoxyriboside control and synchronization of mitosis.

Authors:  N XEROS
Journal:  Nature       Date:  1962-05-19       Impact factor: 49.962

2.  Lymphocyte markers for B- and T-cells in primary immunodeficiency diseases.

Authors:  H U Schwenk; E Gimpert; H J Plüss; U Pilgrim; W H Hitzig
Journal:  Klin Wochenschr       Date:  1974-05-01

3.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

6.  Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.

Authors:  R J Aur; J V Simone; C B Pratt
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

7.  Duration of remissions in lymphoblastic leukaemia of childhood.

Authors:  H C Laurie
Journal:  Br Med J       Date:  1968-04-13

8.  Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation.

Authors:  U Schneider; H zur Hausen
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

9.  Variation of proliferative activity in leukemic cell populations of patients with acute leukemia.

Authors:  E F Saunders; B C Lampkin; A M Mauer
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  5 in total

1.  A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.

Authors:  J Partanen; E Armstrong; T P Mäkelä; J Korhonen; M Sandberg; R Renkonen; S Knuutila; K Huebner; K Alitalo
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Affinity for the nuclear compartment and expression during cell differentiation implicate phosphorylated Groucho/TLE1 forms of higher molecular mass in nuclear functions.

Authors:  J Husain; R Lo; D Grbavec; S Stifani
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

3.  Ectoenzymes on the surface of cells from human lymphoblastoid lines: 5'-nucleotidase and phosphatase.

Authors:  W Gutensohn; L G Gürtler; W Siegert; E Eichler; S Ernst
Journal:  Blut       Date:  1980-12

4.  Phenotyping human leukemic T-cell lines: enzyme markers, surface antigens, and cytogenetics.

Authors:  P J Martin; E R Giblett; J A Hansen
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells.

Authors:  C K Tebbi; D Chervinsky; B K Seon
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.